NICKY NGUYEN: Open Payments
NPI 1861195547 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,186 in 116 payments from 38 companies in 2025. Trend: 2023 $2,988 · 2024 $4,524 · 2025 $3,186
Food & beverage: $2,859Education: $327
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $549 |
| AstraZeneca Pharmaceuticals LP | 11 | $335 |
| Merck Sharp & Dohme LLC | 12 | $288 |
| ABBVIE INC. | 6 | $229 |
| Astellas Pharma US Inc | 9 | $185 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $176 |
| Novartis Pharmaceuticals Corporation | 4 | $116 |
| Lilly USA, LLC | 6 | $115 |
| Agios Pharmaceuticals, Inc. | 2 | $86 |
| GlaxoSmithKline, LLC. | 3 | $83 |
Products named: KEYTRUDA, VENCLEXTA, TECVAYLI, Nubeqa, RYBREVANT, DARZALEX, VERZENIO, ENHERTU.
Industry payments across TX — which companies pay providers there.
